- Home
- APGE vs M Comparison
APGE vs M Comparison
Compare APGE & M Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APGE | M |
|---|---|---|
| Founded | 2022 | 1830 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.2B |
| IPO Year | 2023 | 2002 |
Fundamental Metrics
Financial Performance| Metric | APGE | M |
|---|---|---|
| Price | $81.29 | $21.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 13 |
| Target Price | ★ $109.67 | $20.09 |
| AVG Volume (30 Days) | 751.1K | ★ 5.3M |
| Earning Date | 05-12-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 3.97% |
| EPS Growth | N/A | ★ 12.08 |
| EPS | N/A | ★ 2.32 |
| Revenue | N/A | ★ $22,621,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.37 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $34.34 | $10.99 |
| 52 Week High | $95.32 | $24.41 |
Technical Indicators
Market Signals| Indicator | APGE | M |
|---|---|---|
| Relative Strength Index (RSI) | 48.04 | 63.61 |
| Support Level | $80.52 | $19.40 |
| Resistance Level | $86.42 | $22.92 |
| Average True Range (ATR) | 4.40 | 0.70 |
| MACD | -0.17 | 0.29 |
| Stochastic Oscillator | 54.32 | 80.40 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 430 eponymous stores, 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constituted 64% of 2025 net retail sales.